EMD-35622
SARS-CoV-2 XBB.1 spike glycoprotein (closed-1 state)
EMD-35622
Single-particle2.5 Å
Deposition: 13/03/2023
Map released: 24/05/2023
Last modified: 30/10/2024
Sample Organism:
Severe acute respiratory syndrome coronavirus 2
Sample: SARS-COV-2 XBB.1 spike glycoprotein
Fitted models: 8ios
Deposition Authors: Anraku Y , Kita S , Yajima H, Sasaki J, Sasaki-Tabata K, Maenaka K , Hashiguchi T
Sample: SARS-COV-2 XBB.1 spike glycoprotein
Fitted models: 8ios
Deposition Authors: Anraku Y , Kita S , Yajima H, Sasaki J, Sasaki-Tabata K, Maenaka K , Hashiguchi T
Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants.
Tamura T ,
Ito J ,
Uriu K,
Zahradnik J ,
Kida I ,
Anraku Y ,
Nasser H ,
Shofa M,
Oda Y,
Lytras S ,
Nao N,
Itakura Y ,
Deguchi S,
Suzuki R,
Wang L ,
Begum MM,
Kita S ,
Yajima H,
Sasaki J,
Sasaki-Tabata K,
Shimizu R,
Tsuda M ,
Kosugi Y,
Fujita S ,
Pan L,
Sauter D ,
Yoshimatsu K ,
Suzuki S ,
Asakura H,
Nagashima M,
Sadamasu K,
Yoshimura K,
Yamamoto Y,
Nagamoto T,
Schreiber G ,
Maenaka K ,
Hashiguchi T ,
Ikeda T ,
Fukuhara T ,
Saito A ,
Tanaka S ,
Matsuno K ,
Takayama K ,
Sato K
(2023) Nat Commun , 14 , 2800 - 2800
(2023) Nat Commun , 14 , 2800 - 2800